Laser therapy with deep-sea drug kills prostate cancer cells
A non-surgical treatment for lowrisk prostate cancer, in which doctors inject a light-sensitive drug derived from deep-sea bacteria into a patient’s bloodstream, was shown in a trial to kill cancer cells without destroying healthy tissue. Results of a trial in 413 patients showed that the drug, which is activated with a laser to destroy tumour tissue in the prostate, was so effective that half the patients went into remission, compared with 13.5% in a control group.”These results are excellent news for men with early localised prostate cancer, offering a treatment…
Read More